AI Analysis
AI-generated analysis. Always verify with the original filing.
AstraZeneca PLC reported its total voting rights as of 31 March 2026 and the admission of 491 new ordinary shares to trading on the London Stock Exchange under its employee share schemes.
Key Takeaways
1Total voting rights in AstraZeneca PLC are 1,550,980,823 as of 31 March 2026, based on issued ordinary shares.
2The company admitted 491 new ordinary shares to trading on the London Stock Exchange's Main Market.
3The new shares were issued between 20 March 2026 and 31 March 2026 under a block admission dated 29 January 2021.
4The admitted shares are fully fungible with existing ordinary shares and were issued under employee share schemes.